Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Chordate Medical’s migraine study enters final stage

Since 2018, Chordate Medical has conducted a study on migraine patients to prove clinical efficacy and safety with the nerve modulating treatment method K.O.S. The patient study, conducted in Germany and Finland, is now in its final phase, and the goal is to have an article with the study results submitted to a scientific journal for publication in the spring of 2022.Read the full article at biostock.se: https://www.biostock.se/en/2021/10/chordate-medicals-migraine-study-enters-final-stage/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Arctic Paper and Rottneros are collaborating on sustainable fiber trays in Poland

Arctic Paper and Rottneros have signed a Letter of Intent regarding a 50/50 joint venture in Kostrzyn, Poland with the aim of building a molded fiber tray factory. The start-up of the new factory, which is estimated to generate an annual revenue of 9-11 MEUR, is planned for the end of 2023. The investment is expected to amount to 12-15 MEUR, corresponding to approximately 55-70 MPLN.Production will be suitable for high barrier packaging, modified atmosphere packaging with extended shelf life as well as for packaging with lesser functional demands, all based on Rottneros primary fiber. The

Invitation to telephone conference for Interim Report 1 January - 30 September 2021

Mekonomen’s Interim Report for the third quarter 2021 will be published on Friday, October 29, at 07:30 a.m CET. A telephone conference will be held at 09:00 a.m in English. Mekonomen's CEO Pehr Oscarson and CFO Åsa Källenius will present the results and respond to questions at the English speaking conference. The presentation material will be available from 8:00 a.m CET on October 29 at www.mekonomen.com under the heading Investors/IR Presentations.  Click this link to register for the

BioStock: PolarCool expands market share in France

After signing an initial 6-week evaluation agreement with French rugby team Stade Français to introduce PolarCap in France, PolarCool has signed its second evaluation agreement in France. This time the counterpart is Biarritz Olympique Pays Basque, another team from Top14, the highest league in French rugby.Read the article at biostock.se : https://www.biostock.se/en/2021/10/polarcool-expands-market-share-in-france/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se 

Alligator enters into agreements on subscription commitments with board members and senior executives

The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or "the Company") has previously, subject to approval by the Extraordinary General Meeting on 8 November 2021, resolved to carry out a rights issue of shares with preferential rights for the Company's existing shareholders of approximately SEK 257 million (the "Rights Issue"). Through the press release issued on 7 October 2021 regarding the board's decision to carry out the Rights Issue, Alligator announced that all members of the Company’s board and management with shareholdings in the Company had expressed their

Elkem to test the world's first carbon capture pilot for smelters

Elkem, a global leader in silicon-based advanced materials, today announces that it will test the world’s first carbon capture pilot for silicon smelters at its plant in Rana, Norway. The project has received financial support from Gassnova CLIMIT and is a follow-up to the company’s recently launched climate roadmap to reduce emissions towards net zero while growing supplies to the green transition.The carbon capture pilot is a collaboration between Elkem and Mo Industripark, SINTEF, Alcoa, Celsa, Ferroglobe, SMA Mineral, Norcem, Norfrakalk, Arctic Cluster Team and Aker Carbon Capture.

The Board of Directors of Calmark Sweden AB (publ) resolves to carry out a rights issue of approx. MSEK 24.9 and a directed issue of approx. MSEK 2.1, and brings forward the interim report for Q3 2021

The Board of Directors of Calmark Sweden AB (publ) (“Calmark” or the “Company”) has, on the authority of the Annual General Meeting of 18 May 2021, resolved on a rights issue of not more than 4,611,064 B shares, with preferential rights for existing shareholders in Calmark (the “Rights issue”). The Company has obtained subscription commitments corresponding to approximately 54 percent of the Rights Issue from, inter alia, Wingefors Invest AB and Creades AB (via capital insurance), as well as guarantee commitments corresponding to approximately 26 percent of the Rights Issue from Gainbridge

REPORT ON THE THIRD QUARTER 2021

STRONG SALES GROWTH AND SOLID MARGINS DESPITE SUPPLY CHAIN DISRUPTIONSTHIRD QUARTER 2021 · Net sales were SEK 5,545 m (4,466); an increase of 24%, of which 11% was organic growth. · Operating profit before depreciation and amortization (EBITDA) was SEK 987 m (867), representing a margin of 17.8% (19.4%). · Operating profit (EBIT) before items affecting comparability was SEK 785 m (690), representing a margin of 14.2% (15.5%). · Operating profit (EBIT) was SEK 762 m (676), representing a margin of 13.7% (15.1%). · Profit for the quarter was SEK 480 m (281). · Earnings per

Midsona - Interim report January - September 2021

Increased net sales with improved marginsJuly-September 2021 (third quarter) · Net sales amounted to SEK 893 million (821). · EBITDA amounted to SEK 80 million (72) before items affecting comparability, corresponding to a margin of 9.0 percent (8.8). · Profit for the period was SEK 31 million (34), corresponding to earnings per share of SEK 0.45 (0.52) before dilution and SEK 0.45 (0.51) after dilution. · Free cash flow amounted to SEK –8 million (64). · Midsona agreed to acquire Vitality and Oy, a leading Finnish player in the consumer health products category. ·

Lagercrantz Interim Report 2021/22 Q2

Second quarter (1 July – 30 September 2021) ·  Net revenue increased by 31% to MSEK 1,201 (918).  · Organically, net revenue increased by 13%. · Operating profit (EBITA) increased to MSEK 192 (132), equivalent to an operating margin of 16.0% (14.4). · Profit after financial items increased by 50% to MSEK 156 (104). · Profit after taxes increased by 43% to MSEK 116 (81). · Cash flow from operating activities increased to MSEK 113 (80). · Return on equity was 28% (22). The equity ratio at the end of the period was 34% (40). First six months (1 April – 30

Raute Corporation - Interim Report January 1-September 30, 2021

RAUTE CORPORATION INTERIM REPORT OCTOBER 22, 2021 AT 9:00 a.m. This is a summary of Raute’s Interim Report January 1-September 30, 2021. The complete report is attached to this release as a pdf file and is also available on the company’s’ website at www.raute.com.   RAUTE CORPORATION - INTERIM REPORT JANUARY 1-SEPTEMBER 30, 2021   - The Group’s net sales, EUR 98.1 million (MEUR 76.1), increased 29% on the comparison period. Order intake was very high, at EUR 154 million (MEUR 49).- Operating profit amounted to EUR -1.6 million (MEUR -2.7), up 41% on the comparison period.

Sobi publishes report for the third quarter 2021

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces its results for the third quarter 2021. Total revenue amounted to SEK 3,761 M, a 29 per cent growth at CER compared with the same period 2020. EBITA was SEK 1,166 M, resulting in an EBITA margin of 31 per cent. July – September · Total revenue SEK 3,761 M (2,970), +27 per cent, +29 per cent at constant exchange rates (CER) · Haematology revenue SEK 2,291 M (2,147), +9 per cent at CER of which Elocta® SEK 1,035 M (1,115), -6 per cent at CER, Alprolix® SEK 430 M (435), unchanged at CER, and Doptelet®

Q3 2021: Regional dynamics affecting the quarter

Significant events during the third quarter · Net sales decreased by 18% (-17% adjusted for currency changes) to SEK 159 m (195) in Q3 and decreased by 8% (-1% adjusted for currency changes) to SEK 488 m (532) for the first nine months of the year. The comparative period was positively affected by non-recurring income of around SEK 15 m. · The EBITDA margin was 27% (32%) in Q3 and 26% (28%) for the first nine months of the year. · Work started with Blis Technologies for the start of production and collaboration in the sales organization and R&D. · First tolerance study of two

myFC Holding interim report july – september 2021

Quarter july – september 2021     • Net sales amountes to 0,2 million (0,0)     • Operating profit amounted to -4,8 million (-11,0)     • Earnings per share amounted to -0,03 (-0,07) Significant events July to September    • myFC signs agreement with leading European OEM – evaluation of fuel cell solution for automated warehouse robots (AGV)    • myFC signs cooperation agreement for technical development with global bicycle system manufacturer from Japan    • Patent in India enables a large future market for myFC's technology Significant events after the period end    •

Realfiction updates on its ECHO development and Sales Activities

Realfiction Holding AB (“Realfiction” or “the Company”) announces a general update on its progress in the development of its ECHO holographic display technology and its Sales Activities.A summary of the latest progress per business area is presented below. ECHO developmentTogether with the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP (Fraunhofer FEP), Germany, and Interuniversity Microelectronics Centre (imec), Belgium, Realfiction has been working on completing its ECHO holographic display technology integration license package. The development

Rottneros interim report July-September 2021

Very strong earnings improvements· NET SALES increased by 12 percent to 570 (508) MSEK driven by higher sales prices.  · THE LIST PRICE for NBSK pulp in Europe was 59 percent higher in USD and 55 percent in SEK compared with the third quarter of 2020. The list price has risen from 880 to 1,340 USD per tonne during the period January-September 2021.  · PRODUCED VOLUME amounted to 92.2 (110.2) thousand tonnes, affected by annual maintenance shut downs in both mills. In 2020, no maintenance stops were held in the third quarter.  · SOLD VOLUME amounted to 92.5 (106.9) thousand

Rottneros and Arctic Paper are collaborating on sustainable fiber trays in Poland

Rottneros and Arctic Paper have signed a Letter of Intent regarding a 50/50 joint venture in Kostrzyn, Poland with the aim of building a moulded fiber tray factory. The start-up of the new factory is planned for the end of 2023. The investment is expected to amount to 12-15 MEUR, corresponding to approximately 120-150 MSEK.Production will be suitable for high barrier packaging, modified atmosphere packaging with extended shelf life as well as for packaging with lesser functional demands, all based on Rottneros primary fiber. The products can withstand heat and are excellent for ready-made

Trading in Pagero Group AB’s (publ) shares on Nasdaq First North Growth Market commences today

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONGKONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. OTHER RESTRICTIONS ARE APPLICABLE, PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. Pagero Group AB (publ) (”Pagero” or the “Company”) a growth-oriented, global SaaS company with the aim to build the world’s largest open business network in order to

Interim report January-September 2021

Continued solid development Quarter 3, 2021   · Incoming orders amounted to SEK 1,178m (827), equivalent to currency-neutral growth of 45.1 percent compared with the same period last year. Compared with the corresponding quarter 2019, incoming orders increased currency-neutral by 35.8 percent. · Net sales amounted to SEK 1,046m (826), equivalent to currency-neutral growth of 28.3 percent compared with the same period last year. · Operating profit was SEK 119.3m (63.3), giving an operating margin of 11.4 percent (7.7). · Adjusted operating profit was SEK 119.5m (63.5),

Wallenstam’s Interim report Jan 1–Sep 30, 2021: Business model that generates results

Hans Wallenstam, CEO, and Susann Linde, CFO and Head of Investor Relations, comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CEST) at the latest. An audiocast in English with Susann Linde will take place at 09.30 (CEST) at www.financialhearings.com. The presentation is available at www.wallenstam.se/filmsandpresentations before 09.30 (CEST). January 1–September 30, 2021 · The net asset value per share increased by SEK 8.90 during the period and amounted to SEK 107.20 (98.30). · Income from property management amounted to SEK

Scandi Standard appoints Jonas Tunestål as new managing director and CEO

The Board of Directors of Scandi Standard (SCST SS) has decided to appoint Jonas Tunestål as new managing director and CEO. Tunestål is currently CEO of KLS Ugglarps and Executive Vice President of Danish Crown. Interim managing director and CEO Otto Drakenberg will remain with Scandi Standard until Jonas Tunestål joins the company next year.Jonas Tunestål is appointed new managing director and CEO of Scandi Standard. He has extensive experience from the meat industry, having spent his entire career within KLS Ugglarps in a number of different positions. Since 2014 he has been the CEO of

AnaCardio appoints Patrik Strömberg as CEO

STOCKHOLM, SWEDEN - 22 October 2021: AnaCardio AB announces today that Patrik Strömberg has been appointed Chief Executive Officer effective as of September 1, 2021. Patrik Strömberg joins AnaCardio from his previous role as Vice President, External Innovation, Sourcing & Evaluation at Swedish Orphan Biovitrum AB (Sobi). Patrik has extensive experience from the pharmaceutical industry from senior roles in both R&D and Business Development, and he holds a PhD in biochemistry from Karolinska Institutet and an MBA from Stockholm Business School, Stockholm University. "We are very pleased to

myFC secures funding for the execution of their two proof-of-concept projects

As previously announced, myFC has received two important orders for development projects in the priority segments intralogistics and soft mobility. One from the premium car manufacturer Porsche, which will use the technology in automatic warehouse robots (AGV) at their logistics centre in Leipzig, and one from a major Japanese manufacturer of bicycle systems with a global market– To secure the work in the projects, we have raised loan of 15 million in extra capital, says Michael Glantz, CEO of myFC.The business-to-business strategy that myFC adopted in 2020 is now delivering in the

Autonomous Hauling System for increased productivity in Boliden Aitik

Boliden has decided to introduce an Autonomous Hauling System, Komatsu Frontrunner, on eleven haul trucks in the Aitik mine. The investment is for a total of SEK 218 m and will be fully implemented during 2024. While the production rate in Boliden Aitik remains constant the needed transport work is increasing with the size and depth of the mine. Automation of the haul truck fleet will increase productivity and asset utilization in order to meet increased transportation demands in the mine while retaining world leading cost competitiveness. The introduction of Autonomous Hauling in

There are no items matching the current filter
There are no more items matching the current filter
Back to top